~~<i id='CA1F7FD9A7'><strike id='CA1F7FD9A7'><tt id='CA1F7FD9A7'><pre id='CA1F7FD9A7'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

leisure time

author：comprehensive 2025-09-28 00:48:14 - browse：655

The Food and Drug Administration on Thursday approved a gene therapy to treat people with hemophilia A, an inherited and rare bleeding disorder.

The treatment, called Roctavian, is made by BioMarin Pharmaceutical. It was first approved in Europe in August 2022.

Roctavian is a one-time therapy that, in clinical trials, dramatically reduced bleeding episodes and helped patients live without the blood transfusions used to treat the disease. The FDA first rejected Roctavian in 2020, asking BioMarin to amass more data on its safety and long-term durability, and then delayed its decision again to account for additional evidence.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Princess Kate attends Wimbledon with Roger Federer: See the photos

focus

hotspot

explore

entertainment

focus

leisure time

ActorKevinSpacey,right,arrivesatSouthwarkCrownCourtwhereheisaccusedofsexualoffensesagainstfourmeninB

WSS

Severe weather updates: 1 million customers without power in 11 states as storms pummel East Coast

Former New York Mayor de Blasio and wife announce separation, but not divorce

Kansas bar where gunfire wounded 9 last month closes permanently

Dramatic video released of Russian fighter jets 'harassing' US drones over Syria

Doctors push to include dialysis machines in emergency stockpile

Supreme Court shows surprising restraint in chaotic year of crises: ANALYSIS

explore

leisure time

focus

Tori Bowie and the unacceptable rates of Black maternal death

2 million sign

After affirmative action ruling, medical educators look to 'holistic review'

'Insanity': 4th of July mass shootings across US kill 13, injure more than 80

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Man pleads guilty to raping Ohio girl who ended up traveling across state lines for abortion

Cancer drug shortages should be causing more outrage

Pennsylvania man bitten on the head by bear during attack in his garage

DIEP, the 'gold standard' of breast reconstruction, is under threat

Failure, not just success, should guide future doctors

hotspot

EU moves toward latest gene techniques in food production to counter climate change, shortages

NFL doctors' conflicts of interest could endanger players, report says

Pentagon will tighten controls on classified information after Discord leak

1 in 4 Americans hadn't contracted COVID by the end of 2022, CDC estimates

2 million sign

Former New York Mayor de Blasio and wife announce separation, but not divorce

explore

entertainment

focus

leisure time